5Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines [J]. Radiother Oncol, 2003,69 (3) : 227- 236.
6Chao KS, Majhail N, Huang C J, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques [J]. Radiother Oncol, 2001,61 ( 3 ) : 275-280.
7Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience [J]. Int J Radiat Oncol Biol Phys, 2002,53( 1 ) : 12-22.
8Wolden SL, Chen WC, Pfister DG, et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience [J]. Int J Radiat Oncol Biol Phys, 2006,64( 1 ) :57-62.
9Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function [J]. Cancer, 2004, 101 (7) : 1584-1593.
10Hsiung CY, Ting HM, Huang HY, et al. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2006,66 ( 2 ) : 454-461.
